Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion incidence


 * ; ; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Incidence

 * The reported incidence of major bleeding events in the ACS period varies significantly across clinical trials with best estimates between <1 and 14%.
 * Differences in individual patient’s propensity to experience a bleeding event may contribute to the observed variance in bleeding incidence for NSTEMI patients.
 * The existence of multiple bleeding definitions accounts in part for the disparity of the reported incidence of bleeding complications among NSTEMI patients.